Yan Leyfman, Co-founder and Executive Director of MedNews Week, shared a post on LinkedIn:
“Great presentation about the promise of armored CAR T cells without lymphodepletion therapy at the 2025 The New York Academy of Sciences Frontiers in Cancer Immunotherapy Symposium by Global Immunotherapy Leader Dr. Renier Brentjens of Roswell Park Comprehensive Cancer Center.”
More posts featuring Yan Leyfman.